Most Read Articles
6 days ago
Treatment with nebivolol yields more favourable changes in 24-hour, intradialytic and daytime systolic and diastolic blood pressure variability in patients with intradialytic hypertension, a study has found.
Stephen Padilla, 4 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
2 days ago
The known benefits of coffee drinking keep on growing as a new study suggests that coffee consumption can lower the risk of liver-related hospitalizations.

Folic acid, vitamin B12 supplementation may increase colorectal cancer risk

18 Feb 2019

Supplementation with folic acid and vitamin B12 potentially contributes to an increased risk of colorectal cancer (CRC), according to data from the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) trial.

B-PROOF included 2,524 individuals (mean age 74 years) randomized to receive 2–3 years daily supplementation with folic acid 400 μg plus vitamin B12 500 μg (n=1,257) vs placebo (control; n=1,267) on fracture incidence. Researchers obtained data on cancer incidence from the Netherlands cancer registry.

A total of 314 individuals were diagnosed with any cancer (13.6 percent in the intervention group vs 11.3 percent in the control group), while 68 developed CRC (3.4 percent in the intervention group vs 2.0 percent in the control group) during a median follow up of 78 months.

Multivariable Cox proportional hazards models showed that compared with placebo, folic acid plus vitamin B12 supplementation was associated with a tendency toward a higher risk of any cancer (hazard ratio [HR], 1.25; 95 percent CI, 1.00–1.57) and a significantly elevated risk of CRC (HR, 1.77; 1.08–2.90).

Exploratory analysis stratified by duration of the treatment (2 vs 3 years) revealed that the risk estimate for CRC was slightly weaker, although still significant, in participants with 2 years of folic acid plus vitamin B12 supplementation (HR, 1.72; 1.03–2.88).

The present data indicate that older adults receiving supplementation with combined folic acid and vitamin B12 have a slight excess risk of developing any cancer but a significantly elevated risk of developing CRC, researchers said, adding that the effect on CRC risk is even more pronounced in compliant individuals.

However, additional investigation is needed to ascertain whether the increased cancer risk is due to an individual effect of folic acid or vitamin-B12, or an interactive effect of both supplements combined, they said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Treatment with nebivolol yields more favourable changes in 24-hour, intradialytic and daytime systolic and diastolic blood pressure variability in patients with intradialytic hypertension, a study has found.
Stephen Padilla, 4 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
2 days ago
The known benefits of coffee drinking keep on growing as a new study suggests that coffee consumption can lower the risk of liver-related hospitalizations.